Literature DB >> 25795709

Nerve-Cancer Cell Cross-talk: A Novel Promoter of Tumor Progression.

Phillip Jobling1, Jay Pundavela1, Sonia M R Oliveira1, Séverine Roselli1, Marjorie M Walker2, Hubert Hondermarck3.   

Abstract

Recent studies have revealed the essential role played by nerves in tumor progression. Nerves have been shown to infiltrate the tumor microenvironment and actively stimulate cancer cell growth and dissemination. This mechanism involves the release of neurotransmitters, such as catecholamines and acetylcholine, directly into the vicinity of cancer and stromal cells to activate corresponding membrane receptors. Conversely, the secretion of neurotrophic growth factors by cancer cells drives the outgrowth of nerves in solid tumors. This reciprocal interaction between nerves and cancer cells provides new insights into the cellular and molecular bases of tumorigenesis and points to the potential utility of antineurogenic therapies. This review will discuss our evolving understanding of the cross-talk between nerves and cancer cells. ©2015 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25795709     DOI: 10.1158/0008-5472.CAN-14-3180

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  90 in total

1.  Nerve fibers infiltrate the tumor microenvironment and are associated with nerve growth factor production and lymph node invasion in breast cancer.

Authors:  Jay Pundavela; Severine Roselli; Sam Faulkner; John Attia; Rodney J Scott; Rick F Thorne; John F Forbes; Ralph A Bradshaw; Marjorie M Walker; Phillip Jobling; Hubert Hondermarck
Journal:  Mol Oncol       Date:  2015-05-14       Impact factor: 6.603

2.  Pathological analysis of the superior mesenteric artery boundary in preoperative computed tomography of resectable pancreatic head adenocarcinoma.

Authors:  Meng Lu; Chun-Hui Yuan; Ling-Fu Zhang; Lian-Yuan Tao; Ying Peng; Li-Mei Guo; Gang Li; Dian-Rong Xiu
Journal:  Oncol Lett       Date:  2019-04-18       Impact factor: 2.967

Review 3.  Neural plasticity in pancreatitis and pancreatic cancer.

Authors:  Ihsan Ekin Demir; Helmut Friess; Güralp O Ceyhan
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2015-10-13       Impact factor: 46.802

Review 4.  Neuroimmune Interactions: From the Brain to the Immune System and Vice Versa.

Authors:  Robert Dantzer
Journal:  Physiol Rev       Date:  2018-01-01       Impact factor: 37.312

Review 5.  Autonomic nervous system and cancer.

Authors:  Marta Simó; Xavier Navarro; Victor J Yuste; Jordi Bruna
Journal:  Clin Auton Res       Date:  2018-03-28       Impact factor: 4.435

6.  MAOA promotes prostate cancer cell perineural invasion through SEMA3C/PlexinA2/NRP1-cMET signaling.

Authors:  Lijuan Yin; Jingjing Li; Jing Wang; Tianjie Pu; Jing Wei; Qinlong Li; Boyang Jason Wu
Journal:  Oncogene       Date:  2021-01-08       Impact factor: 9.867

Review 7.  Signaling in the microenvironment of pancreatic cancer: Transmitting along the nerve.

Authors:  Noelle Jurcak; Lei Zheng
Journal:  Pharmacol Ther       Date:  2019-04-29       Impact factor: 12.310

8.  Role of host β1- and β2-adrenergic receptors in a murine model of B16 melanoma: functional involvement of β3-adrenergic receptors.

Authors:  Federica Sereni; Massimo Dal Monte; Luca Filippi; Paola Bagnoli
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2015-08-19       Impact factor: 3.000

9.  Differential expression of miRNAs in pancreatobiliary type of periampullary adenocarcinoma and its associated stroma.

Authors:  V Sandhu; I M Bowitz Lothe; K J Labori; M L Skrede; J Hamfjord; A M Dalsgaard; T Buanes; G Dube; M M Kale; S Sawant; U Kulkarni-Kale; A-L Børresen-Dale; O C Lingjærde; E H Kure
Journal:  Mol Oncol       Date:  2015-11-03       Impact factor: 6.603

10.  Molecular Changes in the Nasal Cavity after N, N-dimethyl-p-toluidine Exposure.

Authors:  June K Dunnick; B Alex Merrick; Amy Brix; Daniel L Morgan; Kevin Gerrish; Yu Wang; Gordon Flake; Julie Foley; Keith R Shockley
Journal:  Toxicol Pathol       Date:  2016-04-20       Impact factor: 1.902

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.